Header cover image

U.K. (FTSE) Biotech Industry Analysis

UpdatedMay 29, 2023
DataAggregated Company Financials
Companies34
  • 7D-1.1%
  • 3M-13.6%
  • 1Y-17.1%
  • YTD-19.2%

Over the last 7 days, the Biotech industry has remained flat, although notably PureTech Health gained 6.4%. As for the longer term, the industry has declined 17% in the last year. As for the next few years, earnings are expected to grow by 24% per annum.

Industry Valuation and Performance

Has the U.K. Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 30 May 2023UK£7.0bUK£1.3b-UK£205,061,887.0023.3x-34x5.5x
Thu, 27 Apr 2023UK£7.1bUK£1.3b-UK£186,168,233.0023.6x-38.1x5.6x
Sat, 25 Mar 2023UK£7.2bUK£1.2b-UK£155,780,060.0025.3x-46.3x5.8x
Mon, 20 Feb 2023UK£7.5bUK£1.2b-UK£150,009,082.0027.4x-49.7x6.4x
Wed, 18 Jan 2023UK£7.7bUK£1.2b-UK£140,658,681.0028.1x-55.1x6.7x
Fri, 16 Dec 2022UK£7.4bUK£1.2b-UK£137,433,972.0025x-54x6.4x
Sun, 13 Nov 2022UK£7.9bUK£1.2b-UK£140,723,058.0024.1x-56.1x6.8x
Tue, 11 Oct 2022UK£521.8bUK£1.2b-UK£151,210,669.0026.4x-3450.8x448.8x
Thu, 08 Sep 2022UK£7.0bUK£1.1b-UK£146,825,946.0033.6x-47.7x6.3x
Sat, 06 Aug 2022UK£7.3bUK£1.1b-UK£201,439,580.0037.6x-36.4x6.6x
Mon, 04 Jul 2022UK£7.0bUK£1.1b-UK£175,260,183.0036.1x-39.7x6.2x
Wed, 01 Jun 2022UK£7.2bUK£1.1b-UK£152,404,084.0038.8x-47.2x6.5x
Fri, 29 Apr 2022UK£7.3bUK£1.1b-UK£139,739,194.0036.1x-52.5x6.6x
Sun, 27 Mar 2022UK£7.2bUK£1.1b-UK£81,219,245.0040.9x-89.3x6.6x
Tue, 22 Feb 2022UK£7.7bUK£1.1b-UK£119,714,746.0032.6x-64.4x7.1x
Thu, 20 Jan 2022UK£9.6bUK£1.1b-UK£123,352,664.0045.3x-77.8x8.8x
Sat, 18 Dec 2021UK£11.0bUK£1.1b-UK£121,081,863.0049.7x-90.6x10.1x
Mon, 15 Nov 2021UK£12.0bUK£1.1b-UK£149,827,014.0069.8x-80.1x11.1x
Wed, 13 Oct 2021UK£11.8bUK£1.1b-UK£148,535,266.0068.1x-79.5x10.7x
Fri, 10 Sep 2021UK£12.5bUK£1.1b-UK£143,503,184.6252.8x-86.9x11.8x
Sun, 08 Aug 2021UK£12.1bUK£1.0b-UK£172,541,949.9129.9x-70.3x11.9x
Sat, 01 May 2021UK£11.5bUK£1.0b-UK£166,311,048.5230.3x-69.3x11.4x
Tue, 02 Feb 2021UK£10.8bUK£1.0b-UK£143,994,708.8133.3x-74.8x10.7x
Fri, 06 Nov 2020UK£9.0bUK£985.1m-UK£119,804,987.8160x-75.1x9.1x
Mon, 10 Aug 2020UK£8.2bUK£992.8m-UK£138,646,257.4554.3x-59.1x8.3x
Price to Earnings Ratio

-70x


Total Market Cap: UK£8.0bTotal Earnings: -UK£114,704,522.81Total Revenue: UK£985.7mTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Biotech Industry Price to Earnings3Y Average -66.5x202120222023
Current Industry PE
  • Investors are pessimistic on the British Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 8.9x is higher than the industry's current PS ratio of 5.5x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 8.5% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does U.K. Biotech compare with similar industries?

GB Market-1.84%
Healthcare-2.14%
Biotech-1.12%
Biotech-1.12%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
PRTC PureTech HealthUK£2.256.4%
+UK£37.2m
21.2%PS49.3x
ETX e-therapeuticsUK£0.1736.2%
+UK£26.4m
-14.8%PS208.8x
BVXP BioventixUK£37.501.4%
+UK£2.8m
0.4%PE23.3x
BSFA BSF EnterpriseUK£0.1618.9%
+UK£2.6m
90.9%PB4.5x
4BB 4basebioUK£5.651.8%
+UK£1.2m
18.9%PS259.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

EVG

UK£0.039

Evgen Pharma

7D

5.4%

1Y

1.3%

SNG

UK£0.084

Synairgen

7D

-13.4%

1Y

-68.3%

GNS

UK£25.02

Genus

7D

-0.3%

1Y

-9.4%

OXB

UK£4.42

Oxford Biomedica

7D

-0.7%

1Y

-14.1%

4BB

UK£5.65

4basebio

7D

1.8%

1Y

18.9%

ETX

UK£0.17

e-therapeutics

7D

36.2%

1Y

-14.8%

PRTC

UK£2.25

PureTech Health

7D

6.4%

1Y

21.2%

AVCT

UK£1.08

Avacta Group

7D

-3.6%

1Y

-15.0%

FARN

UK£2.82

Faron Pharmaceuticals Oy

7D

-3.4%

1Y

25.3%

BVXP

UK£37.50

Bioventix

7D

1.4%

1Y

0.4%

SCLP

UK£0.15

Scancell Holdings

7D

-5.6%

1Y

19.2%

BSFA

UK£0.16

BSF Enterprise

7D

18.9%

1Y

90.9%